Researcher profile

Ronglai Shen

Ronglai Shen contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
3topics
3close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Topical Hidden Genome: Discovering Latent Cancer Mutational Topics using a Bayesian Multilevel Context-learning Approach

Statistical inference on the cancer-site specificities of collective ultra-rare whole genome somatic mutations is an open problem. Traditional statistical methods cannot handle whole-genome mutation data due to their ultra-high-dimensionality and extreme data sparsity -- e.g., >30 million unique variants are observed in the ~1700 whole-genome tumor dataset considered herein, of which >99% variants are encountered only once. To harness information in these rare variants we have recently proposed the "hidden genome model", a formal multilevel multi-logistic model that mines information in ultra-rare somatic variants to characterize tumor types. The model condenses signals in rare variants through a hierarchical layer leveraging contexts of individual mutations. The model is currently implemented using consistent, scalable point estimation techniques that can handle 10s of millions of variants detected across thousands of tumors. Our recent publications have evidenced its impressive accuracy and attributability at scale. However, principled statistical inference from the model is infeasible due to the volume, correlation, and non-interpretability of the mutation contexts. In this paper we propose a novel framework that leverages topic models from the field of computational linguistics to induce an *interpretable dimension reduction* of the mutation contexts used in the model. The proposed model is implemented using an efficient MCMC algorithm that permits rigorous full Bayesian inference at a scale that is orders of magnitude beyond the capability of out-of-the-box high-dimensional multi-class regression methods and software. We employ our model on the Pan Cancer Analysis of Whole Genomes (PCAWG) dataset, and our results reveal interesting novel insights.

preprint2020arXiv

Using the "Hidden" Genome to Improve Classification of Cancer Types

It is increasingly common clinically for cancer specimens to be examined using techniques that identify somatic mutations. In principle these mutational profiles can be used to diagnose the tissue of origin, a critical task for the 3-5% of tumors that have an unknown primary site. Diagnosis of primary site is also critical for screening tests that employ circulating DNA. However, most mutations observed in any new tumor are very rarely occurring mutations, and indeed the preponderance of these may never have been observed in any previous recorded tumor. To create a viable diagnostic tool we need to harness the information content in this "hidden genome" of variants for which no direct information is available. To accomplish this we propose a multi-level meta-feature regression to extract the critical information from rare variants in the training data in a way that permits us to also extract diagnostic information from any previously unobserved variants in the new tumor sample. A scalable implementation of the model is obtained by combining a high-dimensional feature screening approach with a group-lasso penalized maximum likelihood approach based on an equivalent mixed-effect representation of the multilevel model. We apply the method to the Cancer Genome Atlas whole-exome sequencing data set including 3702 tumor samples across 7 common cancer sites. Results show that our multi-level approach can harness substantial diagnostic information from the hidden genome.